Genewity B.V.
Max Renes is a PHD Candidate at Vrije Universiteit Amsterdam, working on "Entrepreneurship in life Sciences" under the supervision of prof dr Eric Claassen at the Athena Institute. Max is also the Co-Founder and COO of Genewity B.V., and has previous experience as a Senior Consultant at FFUND - Life Science and Health consulting. With a background in Biofabrication and Biomedical Sciences, Max has also worked as a Postgraduate Researcher at Intelligent Polymer Research Institute and UMC Utrecht. Max holds a Master of Philosophy from the University of Wollongong, a Master of Science from Utrecht University, and a Bachelor of Science from University College Utrecht.
This person is not in any teams
This person is not in any offices
Genewity B.V.
Genewity B.V. is a recently founded biotech company based in Leiden, the Netherlands. Closely collaborating with the LUmc, we build on successes of our scientific and business teams in cell and gene therapies, including the first multi-centric clinical trial for gene therapy in the EU (the RAG1 SCID trial). Genewity has been founded to commercialize another potentially groundbreaking therapy for developing autologous thymus tissue de novo. Genewity is currently in a preclinical development stage and is engaged in raising a Series A to push the technology to the clinic.